Topics tagged rct

Topic	Replies	Views	Activity
Use of percentage change in clinical trials effect-measures , rct , interpretation	16	625	April 8, 2024
Run-in phase in RCTs research methods rct	14	9647	April 1, 2024
Individual response data analysis design , interpretation , rct	236	34447	March 24, 2024
Communicating statistical concerns to the FDA design , rct , regulatory	3	378	March 11, 2024
Is Lithium Equivalent to Lecanemab in Slowing cognitive decline in Alzheimer's Disease? research methods survival-analysis , interpretation , rct	0	349	February 23, 2024
Prior design in a bayesian re-analysis of an RCT bayes rct	1	246	February 19, 2024
Assessing correlation/surrogacy between 2 estimated treatment effects data analysis meta-analysis , surrogate , rct	9	451	February 17, 2024
Review of Trial at the Center of the Firestorm Over Early Connection of Patients to Ventilators during the Pandemic measurement design , interpretation , rct	34	2869	February 16, 2024
RCT: protocol deviation and implications for analysis research methods rct	6	343	February 16, 2024
Time to pre-randomization monthly seizure count design , survival-analysis , rct	1	178	February 8, 2024
ITT analysis population - RCT design rct	6	784	February 3, 2024
Ranked analysis of ANCOVA modeling strategy design , interpretation , rct	7	601	January 21, 2024
Bayesian Dynamic Borrowing with Robust Mixture Priors: Fair or not? bayes , rct	7	421	January 18, 2024
Language for communicating frequentist results about treatment effects study interpretation confidence-interval , rct , p-value , journal , writing	200	108909	January 9, 2024
Substituting treatment arm with drug exposure (continuous variable) in RCT research methods rct	10	476	January 8, 2024
Encryption of dataset in REDCap data analysis rct , data-management	3	417	December 15, 2023
Mixed models modelling models random-effects , rct	14	1163	October 26, 2023
Summary Statistics vs Raw Data measurement time-to-event , ordinal , rct , multiple-endpoints , critical-care	9	9040	October 23, 2023
Comparing "all active dose" to placebo - do we treat "all active dose" as one group or separate groups? models design , rct , interpretation	2	583	September 4, 2023
Guidance of analysis of longitudinal patient reported outcomes w.r.t Joint models modeling strategy longitudinal , rct , interpretation	4	695	August 29, 2023
Effect modification in series of n-of-1 trials (repeated crossover) modeling strategy rct	2	473	August 25, 2023
Data collected outside of guidelines/window rct	10	1087	June 13, 2023
Different results in unconstrained partial proportional odds model modeling strategy bayes , ordinal , rct	0	714	May 22, 2023
Attrition Sensitive Randomisation design , randomization , missing-data , rct	1	946	April 25, 2023
Randomization in a diagnostic study - necessary? design design , rct	3	952	March 16, 2023
Appropriate model for combined data from two RCTs modeling strategy rct	10	749	March 8, 2023
RCT with missing follow-up outcomes: ANCOVA + MI vs Mixed-Effects Modelling? strategy , missing-data , rct	50	5157	March 7, 2023
FDA "Bad Habits" drug development interpretation , rct	7	1893	March 4, 2023
Resources for handling blocked randomization in the analysis of RCTs modeling strategy rct	10	1335	February 11, 2023
Toward Guidelines for RCT Measurements.. What are the characteristics of an acceptable measurement for RCT? data analysis design , measurement , rct	0	922	February 10, 2023